NYSE : ZBH
Zimmer Biomet Holdings, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 95.45 USD (Oct 30, 2026, 9:48 AM EDT) · Market cap 18.21B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 18.03B |
| Enterprise Value | 25.17B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Sep 30, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 190.74M |
| Shares Outstanding | 190.74M |
| Shares Change (YoY) | -1.95% |
| Shares Change (QoQ) | -1.53% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 106.03% |
| Float | 190.13M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 22.96 |
| Forward PE | 10.80 |
| PS Ratio | 2.12 |
| Forward PS | 2.06 |
| PB Ratio | 1.43 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.02 |
| P/OCF Ratio | 10.34 |
| PEG Ratio | 1.90 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 31.20 |
| EV / Sales | 2.96 |
| EV / EBITDA | 9.97 |
| EV / EBIT | 17.76 |
| EV / FCF | 20.97 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.69 |
| Quick Ratio | 0.74 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 2.94 |
| Debt / FCF | 6.33 |
| Interest Coverage | 4.90 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 6.41% |
| Return on Assets (ROA) | 3.88% |
| Return on Invested Capital (ROIC) | 6.19% |
| Return on Capital Employed (ROCE) | 7.16% |
| Weighted Average Cost of Capital (WACC) | 5.84% |
| Revenue Per Employee | $500,518 |
| Profits Per Employee | $47,453 |
| Employee Count | 17,000 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.10 |
Taxes
| Measure | Value |
|---|
| Income Tax | 126.60M |
| Effective Tax Rate | 13.56% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -5.21% |
| 50-Day Moving Average | 94.85 |
| 200-Day Moving Average | 91.63 |
| Relative Strength Index (RSI) | 49.77 |
| Average Volume (20 Days) | 1,976,924 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 7.96M |
| Short Previous Month | 8.58M |
| Short % of Shares Out | 4.17% |
| Short % of Float | 4.19% |
| Short Ratio (days to cover) | 3.64 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 8.51B |
| Gross Profit | 5.92B |
| Operating Income | 1.42B |
| Pretax Income | 933.60M |
| Net Income | 806.70M |
| EBITDA | 2.53B |
| EBIT | 1.42B |
| Earnings Per Share (EPS) | $4.12 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 464.50M |
| Total Debt | 7.60B |
| Net Cash | -7.14B |
| Net Cash Per Share | -$37.42 |
| Equity (Book Value) | 12.63B |
| Book Value Per Share | 66.23 |
| Working Capital | 2.08B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.74B |
| Capital Expenditures | -543.20M |
| Depreciation & Amortization | 1.11B |
| Net Borrowing | -46.00M |
| Free Cash Flow | 1.20B |
| FCF Per Share | $6.29 |
Margins
| Measure | Value |
|---|
| Gross Margin | 69.52% |
| Operating Margin | 16.65% |
| Pretax Margin | 10.97% |
| Profit Margin | 9.48% |
| EBITDA Margin | 29.68% |
| EBIT Margin | 16.65% |
| FCF Margin | 14.10% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.96 |
| Dividend Yield | 1.02% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 23.32% |
| FCF Payout Ratio | 15.26% |
| Buyback Yield | 1.95% |
| Shareholder Yield | 2.96% |
| Earnings Yield | 4.35% |
| FCF Yield | 6.66% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $106.90 |
| Price Target Difference | 13.10% |
| Analyst Consensus | Buy |
| Analyst Count | 27 |
| Revenue Growth Forecast (3Y) | 3.94% |
| EPS Growth Forecast (3Y) | 5.63% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.51 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |